About Todd Blakely

Todd’s practice involves all aspects of intellectual property including the preparation, prosecution, and litigation and licensing of domestic and international patent, trademark and copyright matters.

With over 30 years of experience, Todd regularly manages intellectual property litigation, mediation, and dispute resolution, licensing of domestic and international patent, trademark and copyright rights, and freedom to operate, non-infringement and invalidity opinions. As manager of the intellectual property portfolios of some clients, Todd also handles preparation and prosecution of patent and trademark rights – developing value-oriented intellectual property portfolios for clients in diverse fields.

Todd’s diverse roster of clients includes electronic hardware manufacturers, access control equipment manufacturers, including RFID, electronic and mechanical security systems and devices, and oil and gas exploration and recovery equipment manufacturers. He also works with banking institutions, cellular equipment, and system providers, entertainment content distribution companies, medical and surgical device manufacturers, international travel and tour operators, photography service providers, personal care product manufacturers, sport eyewear companies, and hospitality companies.

is known that a rapid dose reduction or abrupt withdrawal of Xanax may cause a withdrawal syndrome, the symptoms of which can range from mild dysphoria and insomnia to severe syndrome with abdominal and skeletal muscle spasms, vomiting, increased sweating, tremors and convulsions. Withdrawal syndrome is more common in individuals who have been receiving Xanax for a long time (more than 8-12 weeks).